Gilead's HIV drug gets closer to getting Europe approval

(Reuters) - Gilead Sciences Inc's experimental cocktail to treat HIV received a green light from European regulators on Friday, boosting the chances of the drug being formally approved by the European Commission.

http://ift.tt/1n1pWuo

from Reuters: Health News
via animenewspro